Executive Order 13910, signed on March 23, 2020, invoked the Defense Production Act to authorize the Department of Health and Human Services to combat hoarding and price gouging of critical medical resources during the early stages of the COVID-19 pandemic. The order provided federal authorities with enforcement mechanisms to identify, prevent, and penalize the accumulation and retention of scarce health and medical supplies, particularly ventilators, personal protective equipment, and other equipment essential to pandemic response. By grounding the directive in wartime production authority, the administration created legal tools to redirect supplies toward areas of greatest need and prevent artificial scarcity created by market manipulation or stockpiling.

Healthcare workers, hospital administrators, and patients requiring life-sustaining equipment were directly affected by this order's implementation. The mechanisms established determined who could access ventilators and protective equipment during critical shortages, effectively allocating finite resources across competing healthcare systems and regions. State and local health authorities gained federally-backed authority to enforce compliance, while companies and individuals engaged in hoarding faced potential penalties for withholding supplies from the medical supply chain.

The order represented a limited intervention into healthcare market dynamics during acute crisis conditions. However, the broader trajectory of Trump administration healthcare policy reveals a pattern moving in the opposite direction—away from robust federal oversight and toward deregulation. Subsequent actions including the FDA's authorization of fruit-flavored vapes, restrictions on mifepristone telehealth access, and the dismantling of CDC vaccine recommendations demonstrate a systematic retreat from federal health protections. The administration's redirection of Title X funding away from contraception access and proposed penalties on disabled adults receiving family support further indicate ideological prioritization over evidence-based public health outcomes. Executive Order 13910 stands as an anomaly within this deregulatory framework, a crisis-driven assertion of federal authority that contrasts sharply with the administration's subsequent rollback of protective health policies and restrictions on access to preventive care and medications.